Sep 17, 2018 - 3 High-Quality Biotech Companies for 4th Quarter, Stocks: BIIB,GILD,NVO,BRK.A,BRK.B,AMGN,CELG, Warren Buffett, release date:Sep 17, 2018
Sep 11, 2018 - Alkermes expands a phase I study to evaluate its immuno-oncology candidate, ALKS 4230, in combination with Keytruda in patients with advanced solid tumors.
Sep 11, 2018 - Acorda Therapeutics' (ACOR) stock slumps after a Federal Circuit Court rules against its appeal to protect patents pertaining to its key multiple sclerosis drug, Ampyra
Sep 05, 2018 - While much attention is being riveted on the S&P 500's new all-time high eclipsing the January one, small caps accomplished that in May.Small caps are in their next leg up as they record new all-time
Sep 05, 2018 - Biogen (BIIB) enrolls first patient in a phase III study evaluating BIIB093 for prevention and treatment of severe cerebral edema in large hemispheric infarction.
Aug 17, 2018 - Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Aug 11, 2018 - Biogen's stock got a boost from two material events last month.
Aug 10, 2018 - Country Trust Bank Buys Incyte Corp, First Trust Preferred Securities and Income ETF, Visa Inc, Sells Bristol-Myers Squibb Company, Monsanto Co, Cardinal Health Inc, Stocks: V,XLY,NVS,BIIB,AWK,EW,INCY,FPE,JEC,BND,LOW,MUSA,MO, release date:Aug 10, 2018
Aug 10, 2018 - The prevailing narrative is that drug stocks are not investible because drug pricing is at risk of collapsing.We see drug spending becoming less, not more, of an issue.From such current valuation leve
Aug 10, 2018 - Biotech ETFs draw attention post impressive Q2 results.